Institutions / SymBiosis Capital Partners, LLC

SymBiosis Capital Partners, LLC

CIK 2006045 · Institution · as of Dec 31, 2025
Portfolio value
$109.50M
Positions
11
As of
Dec 31, 2025

Top holdings

Dec 31, 2025
CompanyClassValueShares% of portfolio
Evommune, Inc.EVMNCommon Stock$21.93M1,280,77820.0%
Verastem, Inc.—$15.44M2,000,00014.1%
AmpliTech Group Inc—$13.23M2,555,00012.1%
Precigen, Inc.—$12.54M3,000,00011.5%
Inventiva S.A.—$12.09M2,600,00011.0%
Nuvation Bio Inc.NUVBCommon Stock$11.20M1,250,00010.2%
Rani Therapeutics Holdings, Inc.—$8.51M6,300,0007.8%
Aardvark Therapeutics, Inc.AARDCommon Stock$6.26M476,5955.7%
Clene Inc.CLNNCommon Stock$4.52M770,4954.1%
Generation Bio Co—$3.78M665,0003.4%
Surrozen, Inc.—$3.0K150,0000.0%

Activity

Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.